LRTM1
geneOn this page
Also known as HT017
Summary
LRTM1 (leucine rich repeat transmembrane protein 1, HGNC:25023) is a protein-coding gene on chromosome 3p14.3, encoding Leucine-rich repeat and transmembrane domain-containing protein 1 (Q9HBL6).
Predicted to act upstream of or within positive regulation of synapse assembly. Predicted to be located in membrane.
Source: NCBI Gene 57408 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_020678
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25023 |
| Approved symbol | LRTM1 |
| Name | leucine rich repeat transmembrane protein 1 |
| Location | 3p14.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HT017 |
| Ensembl gene | ENSG00000144771 |
| Ensembl biotype | protein_coding |
| Entrez | 57408 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000273286, ENST00000493075
RefSeq mRNA: 2 — MANE Select: NM_020678
NM_001304389, NM_020678
CCDS: CCDS2876, CCDS77753
Canonical transcript exons
ENST00000273286 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001377954 | 54927905 | 54928059 |
| ENSE00001865191 | 54918231 | 54918892 |
| ENSE00003654869 | 54924619 | 54925215 |
Expression profiles
Bgee: expression breadth broad, 51 present calls, max score 97.73.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 3.2009 / max 2796.4272, expressed in 52 samples.
FANTOM5 promoters (9 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 42537 | 2.2208 | 32 |
| 42536 | 0.5692 | 25 |
| 42539 | 0.1301 | 18 |
| 42535 | 0.1145 | 16 |
| 42538 | 0.0454 | 6 |
| 42540 | 0.0425 | 6 |
| 202778 | 0.0331 | 7 |
| 202777 | 0.0287 | 5 |
| 42541 | 0.0167 | 7 |
Top tissues by expression
244 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pineal body | UBERON:0001905 | 97.73 | gold quality |
| buccal mucosa cell | CL:0002336 | 86.57 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.05 | gold quality |
| pancreatic ductal cell | CL:0002079 | 75.09 | silver quality |
| spleen | UBERON:0002106 | 73.00 | gold quality |
| tibialis anterior | UBERON:0001385 | 68.01 | silver quality |
| pharyngeal mucosa | UBERON:0000355 | 64.32 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 62.24 | silver quality |
| ileal mucosa | UBERON:0000331 | 60.22 | silver quality |
| tendon of biceps brachii | UBERON:0008188 | 60.22 | gold quality |
| vena cava | UBERON:0004087 | 58.69 | gold quality |
| deltoid | UBERON:0001476 | 56.73 | gold quality |
| tendon | UBERON:0000043 | 56.12 | silver quality |
| middle temporal gyrus | UBERON:0002771 | 55.44 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 55.17 | gold quality |
| calcaneal tendon | UBERON:0003701 | 54.61 | gold quality |
| medial globus pallidus | UBERON:0002477 | 54.01 | gold quality |
| primary visual cortex | UBERON:0002436 | 53.99 | silver quality |
| epithelial cell of pancreas | CL:0000083 | 53.81 | gold quality |
| quadriceps femoris | UBERON:0001377 | 53.74 | gold quality |
| cerebellar vermis | UBERON:0004720 | 52.31 | gold quality |
| vastus lateralis | UBERON:0001379 | 52.16 | gold quality |
| occipital lobe | UBERON:0002021 | 51.04 | silver quality |
| globus pallidus | UBERON:0001875 | 51.01 | gold quality |
| lower lobe of lung | UBERON:0008949 | 50.60 | silver quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.60 | gold quality |
| oviduct epithelium | UBERON:0004804 | 49.43 | gold quality |
| blood vessel layer | UBERON:0004797 | 49.29 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 49.20 | gold quality |
| hair follicle | UBERON:0002073 | 49.18 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7316 | yes | 865.74 |
| E-GEOD-137537 | yes | 22.05 |
| E-ANND-3 | no | 2.42 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
5 targeting LRTM1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-182-5P | 99.87 | 74.03 | 2589 |
| HSA-MIR-3922-3P | 99.25 | 64.96 | 1136 |
| HSA-MIR-511-5P | 98.97 | 70.94 | 2268 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | lrtm1 | ENSDARG00000098742 |
| mus_musculus | Lrtm1 | ENSMUSG00000045776 |
| rattus_norvegicus | ENSRNOG00000067759 |
Paralogs (22): DCN (ENSG00000011465), RTN4R (ENSG00000040608), ASPN (ENSG00000106819), FLRT3 (ENSG00000125848), FLRT1 (ENSG00000126500), LRRC4 (ENSG00000128594), LRRC4B (ENSG00000131409), PODNL1 (ENSG00000132000), LRRC4C (ENSG00000148948), LRRTM1 (ENSG00000162951), LRRC15 (ENSG00000172061), PODN (ENSG00000174348), LRRTM4 (ENSG00000176204), BGN (ENSG00000182492), LRRC19 (ENSG00000184434), FLRT2 (ENSG00000185070), GP1BA (ENSG00000185245), RTN4RL1 (ENSG00000185924), RTN4RL2 (ENSG00000186907), NYX (ENSG00000188937), LRRC66 (ENSG00000188993), LRRTM3 (ENSG00000198739)
Protein
Protein identifiers
Leucine-rich repeat and transmembrane domain-containing protein 1 — Q9HBL6 (reviewed: Q9HBL6)
All UniProt accessions (1): Q9HBL6
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9HBL6-1 | 1 | yes |
| Q9HBL6-2 | 2 |
RefSeq proteins (2): NP_001291318, NP_065729* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000483 | Cys-rich_flank_reg_C | Domain |
| IPR001611 | Leu-rich_rpt | Repeat |
| IPR003591 | Leu-rich_rpt_typical-subtyp | Repeat |
| IPR032675 | LRR_dom_sf | Homologous_superfamily |
| IPR050541 | LRR_TM_domain-containing | Family |
Pfam: PF13855
UniProt features (19 total): repeat 5, domain 2, glycosylation site 2, sequence variant 2, topological domain 2, signal peptide 1, chain 1, region of interest 1, compositionally biased region 1, splice variant 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9HBL6-F1 | 81.71 | 0.67 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 104, 147
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 39 (showing top):
CAGCTG_AP4_Q5, EVI1_05, FREAC3_01, WTGAAAT_UNKNOWN, MODULE_207, P53_DECAMER_Q2, chr3p14, OSF2_Q6, RP58_01, E47_02, ATF2_UP.V1_UP, BRCA1_DN.V1_UP, CTIP_DN.V1_UP, ZNF7_TARGET_GENES, MIR10527_5P
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
678 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LRTM1 | CORIN | Q9Y5Q5 | 431 |
| LRTM1 | ERC2 | O15083 | 383 |
| LRTM1 | CACNA2D3 | Q8IZS8 | 382 |
| LRTM1 | CACNG6 | Q9BXT2 | 353 |
| LRTM1 | CCL3L1 | P16619 | 353 |
| LRTM1 | STAT6 | P42226 | 349 |
| LRTM1 | ACTR8 | Q9H981 | 345 |
| LRTM1 | ADPRHL1 | Q8NDY3 | 333 |
| LRTM1 | HEPHL1 | Q6MZM0 | 328 |
| LRTM1 | KIAA0586 | Q9BVV6 | 322 |
| LRTM1 | C21orf58 | P58505 | 320 |
| LRTM1 | TMEM215 | Q68D42 | 314 |
| LRTM1 | TRPM1 | Q7Z4N2 | 309 |
| LRTM1 | FAM81B | Q96LP2 | 308 |
| LRTM1 | OPN1SW | P03999 | 306 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MAL | LRTM1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LRTM1 | PTPRF | psi-mi:“MI:0914”(association) | 0.350 |
| MAL | LRTM1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (7): PITHD1 (Affinity Capture-MS), MAL (Two-hybrid), PTPRF (Affinity Capture-MS), GNPDA2 (Affinity Capture-MS), UBA3 (Affinity Capture-MS), ATPAF2 (Affinity Capture-MS), NAE1 (Affinity Capture-MS)
ESM2 similar proteins: A3KNN3, A4IFA6, A6H789, A6H793, A6NDA9, A8WHP9, E7FE13, O08644, O08742, O08770, O14498, O15197, P0C0K6, P0C0K7, P14616, P14617, P21709, P54760, P54761, P59034, P59035, Q149C3, Q3ZBI5, Q5BK65, Q5JZY3, Q5NVQ6, Q5R7M3, Q60750, Q62178, Q64716, Q6GU68, Q6P7C4, Q6PFC5, Q6UY18, Q80ZD5, Q86SJ2, Q86WK7, Q86YC3, Q8BGX3, Q8BMT4
Diamond homologs: A3KNN3, A6H789, A6H793, A6NJW4, A8WHP9, E7FE13, F1MLX5, G5EFX6, O02678, O02833, O35367, O46378, O46379, O46542, O60938, O62702, O75093, O75094, O88279, O88280, O94813, P07359, P07585, P21793, P24014, P28654, P28675, P35858, P35859, P51884, P51885, P51886, P51888, P51890, P58874, P59034, P59035, P70186, P70389, P83286
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
481 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:54918891:CCCTT:C | acceptor_gain | 1.0000 |
| 3:54918892:CCTT:C | acceptor_gain | 1.0000 |
| 3:54918895:T:TC | acceptor_gain | 1.0000 |
| 3:54918889:CCCC:C | acceptor_gain | 0.9900 |
| 3:54918890:CCC:C | acceptor_gain | 0.9900 |
| 3:54918890:CCCC:C | acceptor_gain | 0.9900 |
| 3:54918891:CC:C | acceptor_gain | 0.9900 |
| 3:54918891:CCCT:C | acceptor_loss | 0.9900 |
| 3:54918892:CC:C | acceptor_loss | 0.9900 |
| 3:54918893:C:CC | acceptor_gain | 0.9900 |
| 3:54918893:C:CG | acceptor_loss | 0.9900 |
| 3:54918894:T:A | acceptor_loss | 0.9900 |
| 3:54918894:T:C | acceptor_gain | 0.9900 |
| 3:54918895:T:C | acceptor_gain | 0.9900 |
| 3:54918888:TCCCC:T | acceptor_gain | 0.9800 |
| 3:54918889:CCCCC:C | acceptor_gain | 0.9800 |
| 3:54918893:C:T | acceptor_gain | 0.9800 |
| 3:54927899:GCTCA:G | donor_loss | 0.9800 |
| 3:54927900:CTCA:C | donor_loss | 0.9800 |
| 3:54927901:TCACC:T | donor_loss | 0.9800 |
| 3:54927902:CACC:C | donor_loss | 0.9800 |
| 3:54927903:A:C | donor_loss | 0.9800 |
| 3:54927904:CCTT:C | donor_loss | 0.9800 |
| 3:54925141:G:T | donor_gain | 0.9600 |
| 3:54918894:T:TC | acceptor_gain | 0.9500 |
| 3:54918903:C:CT | acceptor_gain | 0.9500 |
| 3:54927898:GGCTC:G | donor_loss | 0.9300 |
| 3:54918904:A:T | acceptor_gain | 0.9200 |
| 3:54918892:CCTTT:C | acceptor_gain | 0.9000 |
| 3:54918893:CTTT:C | acceptor_gain | 0.8900 |
AlphaMissense
2234 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:54924677:C:A | W182C | 0.992 |
| 3:54924677:C:G | W182C | 0.992 |
| 3:54924679:A:G | W182R | 0.988 |
| 3:54924679:A:T | W182R | 0.988 |
| 3:54924909:A:G | L105P | 0.985 |
| 3:54918868:C:G | C210S | 0.983 |
| 3:54918869:A:T | C210S | 0.983 |
| 3:54924672:C:G | C184S | 0.983 |
| 3:54924673:A:T | C184S | 0.983 |
| 3:54924915:A:G | L103S | 0.983 |
| 3:54925038:A:G | I62T | 0.982 |
| 3:54924987:A:G | L79S | 0.981 |
| 3:54925053:A:G | L57S | 0.981 |
| 3:54925116:C:G | C36S | 0.979 |
| 3:54925117:A:T | C36S | 0.979 |
| 3:54925014:A:C | F70C | 0.978 |
| 3:54918868:C:T | C210Y | 0.977 |
| 3:54924971:A:C | N84K | 0.977 |
| 3:54924971:A:T | N84K | 0.977 |
| 3:54925059:A:G | L55P | 0.974 |
| 3:54924828:T:A | N132I | 0.973 |
| 3:54924899:A:C | N108K | 0.973 |
| 3:54924899:A:T | N108K | 0.973 |
| 3:54924981:A:G | L81S | 0.971 |
| 3:54925115:G:C | C36W | 0.971 |
| 3:54924924:A:C | L100W | 0.970 |
| 3:54924843:A:G | L127P | 0.969 |
| 3:54925044:T:A | N60I | 0.968 |
| 3:54918869:A:G | C210R | 0.967 |
| 3:54924678:C:G | W182S | 0.967 |
dbSNP variants (sampled 300 via entrez): RS1000028458 (3:54932504 A>T), RS1000066392 (3:54965680 G>A), RS1000080299 (3:54932659 T>G), RS1000183555 (3:54964551 C>A,T), RS1000187815 (3:54936929 G>A,C,T), RS1000194215 (3:54961514 A>C), RS1000235094 (3:54958227 G>A), RS1000245591 (3:54944120 T>A), RS1000323717 (3:54938528 C>T), RS1000502742 (3:54922714 A>G), RS1000519075 (3:54965589 G>C), RS1000556598 (3:54923052 A>G), RS1000582851 (3:54942946 C>G,T), RS1000623094 (3:54950132 T>C), RS1000626051 (3:54954357 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002304_24 | Fractional exhaled nitric oxide (childhood) | 3.000000e-06 |
| GCST003542_189 | Night sleep phenotypes | 6.000000e-06 |
| GCST008171_30 | Platelet aggregation | 5.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005536 | nitric oxide exhalation measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs6806020 | CACNA2D3, LRTM1 | 0.00 | 0 |
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Valproic Acid | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.